Start-Up Spotlight: Paragonix Wants To Put 'More Heart' Into Transporting Organs
Paragonix Technologies, which developed the first CE-marked and US FDA-cleared medical device system for transporting donor hearts, is ramping-up marketing in Europe and the US while continuing to expand its technology platform to kidney and lung transplants.
You may also be interested in...
FDA approved a PMA supplement to allow TransMedics' Organ Care System (OCS) to be used for the preservation and ex-vivo assessment of lungs that would not be acceptable for transplant if they had been preserved with a standard cold static system.
NeuroMetrix plans to market the prescription-based Quell in the fourth quarter to US rheumatologists and pain medicine physicians.
Globus Medical CFO Keith Pfeil said “enthusiasm is great” with “more than double-digit orders” for the Excelsius3D system.